Susquehanna Fundamental Investments’s Emergent Biosolutions EBS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$260K	Sell	31,265 -63,805	-67%	-$661K	0.01%	427
2025 Q4	$1.18M	Hold	95,070	–	–	0.04%	325
2025 Q3	$839K	Sell	95,070 -13,240	-12%	-$103K	0.03%	365
2025 Q2	$691K	Hold	108,310	–	–	0.02%	505
2025 Q1	$526K	Buy	108,310 +9,579	+10%	+$79.3K	0.01%	831
2024 Q4	$944K	Buy	+98,731	New	+$906K	0.01%	720
2024 Q2	$677K	Sell	99,254 -19,393	-16%	-$83.5K	0.02%	627
2024 Q1	$300K	Buy	+118,647	New	+$267K	0.01%	554
2022 Q4	–	Sell	-114,214	Closed	-$2.4M	–	1275
2022 Q3	$2.4M	Buy	+114,214	New	+$3.18M	0.04%	521
2022 Q1	$1.11M	Buy	26,941 +235	+0.9%	+$10.4K	0.02%	792
2021 Q4	$1.16M	Sell	26,706 -12,221	-31%	-$553K	0.03%	591
2021 Q3	$1.95M	Buy	+38,927	New	+$2.36M	0.04%	606
2021 Q2	–	Sell	-21,896	Closed	-$2.03M	–	1682
2021 Q1	$2.03M	Buy	21,896 +3,768	+21%	+$386K	0.03%	642
2020 Q4	$1.62M	Buy	18,128 +2,414	+15%	+$222K	0.03%	690
2020 Q3	$1.62M	Buy	+15,714	New	+$1.69M	0.05%	498

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna Fundamental Investments's EBS Position: Q1 2026 in Review

Susquehanna Fundamental Investments reduced its Emergent Biosolutions (EBS) stake by 67% in Q1 2026, selling an estimated $661K and leaving 31,265 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #427.

Susquehanna Fundamental Investments first reported a position in EBS in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.4M in Q3 2022. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Susquehanna Fundamental Investments held 31,265 shares of Emergent Biosolutions worth $260K as of Q1 2026.
Susquehanna Fundamental Investments sold 63,805 Emergent Biosolutions shares in Q1 2026, an estimated $661K.
Emergent Biosolutions made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2026, its #427 holding.
Susquehanna Fundamental Investments first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 15 quarters since.
Susquehanna Fundamental Investments's Emergent Biosolutions position peaked at $2.4M in Q3 2022.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.